Pharmstandard, a leading Russian pharmaceuticals company, saw revenue grow by 23.3% in 2010 to 29.719 billion rubles ($1.007 billion) to IFRS, the company said on Tuesday.
Total sales of pharmaceutical products amounted to 29.089 billion rubles last year, a 24.3% increase compared with 2009. Sales of the company's products, third-party products excluded, increased by 11.5% to 19.229 billion rubles.
Revenue from medical equipment sales stood at 630 million rubles.
Export of the company's pharmaceutical products increased by 38.8% to 593 million rubles in 2010, from 427 million rubles in 2009.
Pharmstandard plans to increase exports to Afghanistan, Argentina, Egypt, Iran, Iraq, Nicaragua, Nigeria, Ukraine, the United Arab Emirates and Venezuela.
MOSCOW, February 15 (RIA Novosti)